Astra wins FDA priority review for Daiichi's Datroway; denied approval for lupus therapy
2026-02-03 08:19:28 ET
More on AstraZeneca PLC, Daiichi Sankyo Company
- Daiichi Sankyo Company, Limited (DSNKY) Q3 FY2025 Earnings Call Transcript
- 44th Annual J.P. Morgan Healthcare Conference
- AstraZeneca PLC (AZN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- AstraZeneca's Enhertu and Genentech's Perjeta combo gains breast cancer approval
- Daiichi Sankyo partnering with General Proximity on oncology targets
Read the full article on Seeking Alpha
For further details see:
Astra wins FDA priority review for Daiichi’s Datroway; denied approval for lupus therapyNASDAQ: DSNKY
DSNKY Trading
0.28% G/L:
$17.72 Last:
462,303 Volume:
$17.70 Open:



